Nanomedicine and drug delivery strategies for treatment of inflammatory bowel disease

doi:10.3748/wjg.v21.i40.11343

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 40

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11179)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

747

WORD

271

HTML

5492

Tables (1-3)

269

Sum=6779

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

517

Download

1280

Sum=1797

Publishing Process of This Article

Item

Count

Browse

1076

Download

1527

Sum=2603

Oct 28, 2015 (publication date) through Feb 24, 2025

Times Cited of This Article

Times Cited (36)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Oct 28, 2015; 21(40): 11343-11352
Published online Oct 28, 2015. doi: 10.3748/wjg.v21.i40.11343

Table 3 Administration of anti-inflammatory mediators

Mediator	Delivery system	Administration	Ref.
IL-10
IL-10	L. lactis	Oral	[65]
IL-10	Gelatin microspheres	Rectal	[66]
IL-10	NiMOS	Oral	[67]
Other anti-inflammatory molecules
TNF-neutralization	L. lactis	Oral	[68]
PHB1	PEI-PVA	Oral	[70]
TFF	L. lactis	Oral	[72]
KPV	PLA	Oral	[74]
IL-27	L. lactis	Oral	[77]

L. lactis: Lactococcus lactis; NiMOS: Nanoparticles-in-microspheres oral system; PEI-PVA: Polyethyleneimine/polyvinyl alcohol; PLA: Polylactide.

Citation: Takedatsu H, Mitsuyama K, Torimura T. Nanomedicine and drug delivery strategies for treatment of inflammatory bowel disease. World J Gastroenterol 2015; 21(40): 11343-11352
URL: https://www.wjgnet.com/1007-9327/full/v21/i40/11343.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i40.11343